Callan Family Office’s Synopsys SNPS Stock Holding History
Bought
Maintained
Sold
Other funds holding SNPS
NC
Callan Family Office's SNPS Position: Q2 2026 in Review
Callan Family Office increased its Synopsys (SNPS) stake by 24% in Q2 2026, buying an estimated $650K and bringing the position to 7,088 shares worth $3.16M. The position accounts for 0.06% of the portfolio, ranked #275.
Callan Family Office first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. 1,450 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.
- Callan Family Office held 7,088 shares of Synopsys worth $3.16M as of Q2 2026.
- Callan Family Office bought 1,382 Synopsys shares in Q2 2026, an estimated $650K.
- Synopsys made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #275 holding.
- Callan Family Office first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
- 1,450 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.